Menarini - Von Heyden GmbH
Menarini - Von Heyden GmbH, headquartered in Germany, is a prominent player in the pharmaceutical industry, specialising in contract manufacturing and development services. Founded in 2010, the company has established a strong presence across Europe, focusing on high-quality production of solid dosage forms, including tablets and capsules. With a commitment to innovation and quality, Menarini - Von Heyden GmbH offers unique solutions tailored to meet the specific needs of its clients. The company is renowned for its state-of-the-art facilities and adherence to stringent regulatory standards, ensuring the delivery of safe and effective products. As a subsidiary of the Menarini Group, it has achieved significant milestones, positioning itself as a trusted partner in the pharmaceutical sector. Its dedication to excellence and customer satisfaction has solidified its reputation in the competitive landscape of contract manufacturing.
DitchCarbon Score
How does Menarini - Von Heyden GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Menarini - Von Heyden GmbH's score of 20 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Menarini - Von Heyden GmbH's reported carbon emissions
Menarini - Von Heyden GmbH, headquartered in Germany, currently does not have available carbon emissions data for the most recent year. As such, specific figures regarding their Scope 1, 2, or 3 emissions are not provided. In the absence of detailed emissions data, it is important to note that the company has not outlined any specific reduction targets or initiatives related to carbon emissions. This lack of publicly available information on their climate commitments suggests that Menarini - Von Heyden GmbH may still be in the early stages of developing a comprehensive sustainability strategy. As the pharmaceutical industry increasingly prioritises climate action, it will be essential for Menarini - Von Heyden GmbH to establish clear goals and transparent reporting to align with global climate standards and expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Menarini - Von Heyden GmbH is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
